Author

Jennifer Callaghan

Observed names: Callaghan J, Callaghan, J, J Callaghan, J. Callaghan, Jenny Callaghan

Observed institutions: University of British Columbia, University of Leicester, Inserm, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Birmingham and Solihull Mental Health NHS Foundation Trust, University of Manchester, St Mary's Hospital, Salford Royal Hospital, Leicestershire Partnership NHS Trust, Institut du Cerveau, European Huntington's Disease Network, UCL Queen Square Institute of Neurology, University College London, Cardiff University

OpenAlex ID: A5020716774

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

2017 · Davina J Hensman Moss, Antonio F Pardiñas, et al. · The Lancet Neurology · 310

PDF

MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1

2019 · Michael Flower, Vilija Lomeikaite, et al. · Brain · 165

PDF

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD

2017 · Scott A. Schobel, Giuseppe Palermo, et al. · Neurology · 155

PDF

Reliability and Factor Structure of the Short Problem Behaviors Assessment for Huntington’s Disease (PBA-s) in the TRACK-HD and REGISTRY studies

2015 · Jenny Callaghan, Cheryl Stopford, et al. · Journal of Neuropsychiatry · 89

Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington's disease

2012 · Izelle Labuschagne, Rebecca Jones, et al. · Psychiatry Research · 57

Clinical manifestations of intermediate allele carriers in Huntington disease

2016 · Esther Cubo, María A. Ramos-Arroyo, et al. · Neurology · 53

Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study

2018 · Paul McNulty, Richard Pilcher, et al. · Journal of Huntington s Disease · 35

Longitudinal expression changes are weak correlates of disease progression in Huntington’s disease

2020 · Christopher T Mitchell, Irina Krier, et al. · Brain Communications · 9

Meaningful and Measurable Health Domains in Huntington’s Disease: Large-Scale Validation of the Huntington’s Disease Health-Related Quality of Life Questionnaire Across Severity Stages

2019 · Aileen K. Ho, Mike C. Horton, et al. · Value in Health · 9

Intellectual enrichment and genetic modifiers of cognition and brain volume in Huntington’s disease

2022 · Marina Papoutsi, Michael Flower, et al. · Brain Communications · 5

PDF

Exploring the Structural Relationship Between Interviewer and Self-Rated Affective Symptoms in Huntington’s Disease

2016 · John Maltby, Maria Dale, et al. · Journal of Neuropsychiatry · 2

PDF

G04 An exploratory analysis of the sensitivity of the Montreal Cognitive Assessment in Huntington's Disease

2010 · R Fullam, E Howard, et al. · Journal of Neurology Neurosurgery & Psychiatry · 1

F24 Differences in companion and subject ratings of subjects' behaviour using the frontal systems behaviour scale (FrSBe)- findings from the track-hd study

2010 · J Callaghan, D Craufurd, et al. · Journal of Neurology Neurosurgery & Psychiatry · 1

K010 Enroll-HD: data quality and performance monitoring

2024 · Jenny Callaghan, Jennifer Ware, et al.

PDF

A16 Problem Behaviours Assessment For HD (short Version) Introductory Training Session

2014 · J. Callaghan · Journal of Neurology Neurosurgery & Psychiatry

DIFFERENCES IN COMPANION AND SUBJECT RATINGS OF SUBJECTS' BEHAVIOUR USING THE FRONTAL SYSTEMS BEHAVIOUR SCALE (FrSBe)- FINDINGS FROM THE TRACK-HD STUDY

2010 · Callaghan, J, Craufurd, D, et al. · UCL Discovery (University College London)

Poster 9: The Short Version of the Problem Behaviours Assessment for HD (PBA-s): An Item Response Analysis Using Data from the TRACK-HD Study

2010 · K. Evans, A. Vaccarino, et al. · Neurotherapeutics

Poster 8: Reliability of the Problem Behaviours Assessment for HD (short version)–Data From the TRACK-HD Study

2010 · J. Callaghan, N. Arran, et al. · Neurotherapeutics

Third Annual Huntington Disease Clinical Research Symposium

2010 · PREDICT-HD Investigators of the Huntington Study Group, Richard Dubinsky, et al. · Neurotherapeutics

PDF

Works count: 28

Citation count: 1,936

H-index: 12

I10-index: 12